Targeted treatment for osteoarthritis: drugs and delivery system
The management of osteoarthritis (OA) is a clinical challenge due to the particular avascular, dense, and occluded tissue structure. Despite numerous clinical reports and animal studies, the pathogenesis and progression of OA are still not fully understood. On the basis of traditional drugs, a large...
Main Authors: | Liwei Mao, Wei Wu, Miao Wang, Jianmin Guo, Hui Li, Shihua Zhang, Jiake Xu, Jun Zou |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2021.1971798 |
Similar Items
-
Current Nanoparticle-Based Technologies for Osteoarthritis Therapy
by: Guang-Zhen Jin
Published: (2020-11-01) -
Nanoparticle–Cartilage Interaction: Pathology-Based Intra-articular Drug Delivery for Osteoarthritis Therapy
by: Xu Li, et al.
Published: (2021-06-01) -
Development and Prospect of Intra-Articular Injection in the Treatment of Osteoarthritis: A Review
by: Zhang Y, et al.
Published: (2020-08-01) -
Hyaluronic acid-alendronate conjugate: A macromolecular drug delivery system for intra-articular treatment of osteoarthritis
by: Stefano Pluda, et al.
Published: (2021-06-01) -
Intra-articular injection of kartogenin-conjugated polyurethane nanoparticles attenuates the progression of osteoarthritis
by: Wenshuai Fan, et al.
Published: (2018-01-01)